Angiotensin II, the main effector in RAAS, acts on the AT1 receptor and causes vasoconstriction, aldosterone secretion, cell proliferation, vascular remodeling, endothelial dysfunction, and atherosclerosis [6, 7]. This evidence concerns the gene AGT and endothelial dysfunction.